COHR.NYSECoherent CORP

Form 4: Coherent Corp. Executive Sells Shares Under 10b5-1 Plan, Updates Power of Attorney

Sentiment:

SEC Form 4 Filing


Christopher Koeppen, EVP of Aerospace & Defense at Coherent Corp., sold 6,154 shares of common stock at $80 per share on May 13, 2025, under a pre-arranged 10b5-1 trading plan, and the company updated its power of attorney.

Summary

  • Christopher Koeppen, EVP of Aerospace & Defense at Coherent Corp., executed a sale of 6,154 shares of common stock on May 13, 2025.
  • The sale was conducted at a price of $80 per share.
  • This transaction was executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 9, 2024.
  • Following the transaction, Koeppen directly owns 50,212 shares of Coherent Corp. common stock.
  • He also indirectly owns shares through his daughter and son.
  • Koeppen also exercised options to acquire 6,154 shares at a price of $36.56.
  • The options fully vested in four equal annual installments beginning on August 28, 2020.
  • Separately, Jeffrey W. Acre appointed Aaron Wax, Chris Forrester, and Yian Huang as substitute attorneys-in-fact, effective March 18, 2025, to execute Forms 3, 4, and 5 on behalf of several individuals, including Christopher Koeppen.

Sentiment

Score: 6

Explanation: The document primarily reports routine transactions (stock sale under 10b5-1 plan, power of attorney update). While the stock sale could be perceived negatively, the pre-planned nature mitigates concern. Overall, neutral sentiment.

Positives

  • The use of a 10b5-1 trading plan suggests a pre-planned and transparent approach to stock sales, potentially mitigating concerns about insider trading.

Negatives

  • The sale of shares by an executive could be perceived negatively by some investors, although the 10b5-1 plan mitigates this concern.

Risks

  • Executive stock sales, even under 10b5-1 plans, can sometimes create short-term price volatility.

Future Outlook

The document does not contain specific forward-looking statements regarding the company's future performance.

Industry Context

Executive stock sales are a common occurrence in publicly traded companies. The use of a 10b5-1 plan is a standard practice to avoid insider trading concerns. Power of attorney updates are routine administrative matters.

Comparison to Industry Standards

  • Executive compensation and stock ownership are typical for companies of Coherent Corp.'s size and industry.
  • The use of 10b5-1 trading plans is a common practice among executives at publicly traded companies to manage their stock sales in compliance with SEC regulations.
  • Comparable companies such as IPG Photonics and Lumentum also see regular Form 4 filings related to executive stock transactions.

Stakeholder Impact

  • The stock sale may have a minor impact on shareholders due to the potential for short-term price fluctuations.

Key Dates

DateDescription
August 28, 2020Options fully vested in four equal annual installments beginning on this date.
December 9, 2024Date the Rule 10b5-1 trading plan was adopted by the reporting person.
March 18, 2025Date of the Substitute Power of Attorney execution.
May 13, 2025Date of the stock sale and option exercise.
May 14, 2025Date of signature of the Form 4 by Christopher M. Forrester, Attorney-in-Fact.

Keywords

Coherent Corp, Christopher Koeppen, stock sale, Form 4, 10b5-1 plan, power of attorney, insider trading

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.